StockData
Tyra Biosciences, Inc. logo

Tyra Biosciences, Inc. (TYRA) KPIs and segments

TYRANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 7/30
$19.57−0.17 (-0.86%)

Close on Nov 17, 2026Market cap $1.17BP/E –Yield –

KPIs & segments

Operating metrics and segments that drive Tyra Biosciences's business

Coming soon

This tab will track the numbers specific to Tyra Biosciences's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.

See a number that looks wrong?